Denny Kraichely Joins Editorial Advisory Board of BioPharm International

August 12, 2008
BioPharm International Editors

Denny Kraichely, PhD, principal research scientist and group leader of pharmaceutical development and marketed product support at Centocor R&D, Inc. (Radnor, PA), a Johnson & Johnson Company, has joined the Editorial Advisory Board of BioPharm International.

Denny Kraichely, PhD, principal research scientist and group leader of pharmaceutical development and marketed product support at Centocor R&D, Inc. (Radnor, PA), a Johnson & Johnson Company, has joined the Editorial Advisory Board of BioPharm International.

At Centocor, Kraichely plays a very active role in identifying, evaluating, and implementing innovative technologies to support an ambitious research and development pipeline. Before joining Centocor in late-2001, he was a molecular biologist in cardiovascular discovery research at Procter and Gamble Pharmaceuticals (Cincinnati, OH). Kraichely received a PhD in Pharmacological and Physiological Science from Saint Louis University (1995–1999), and was a post-doctoral fellow in the Departments of Molecular Integrative Physiology and Cell Structural Biology at the University of Illinois at Urbana-Champaign (1999-2000). Over the past decade, he has authored 16 manuscripts in peer-reviewed journals and review chapters and has presented data at 40 scientific research conferences.

Related Content:

News